Is Psoriasis Genetic? What Your DNA Reveals About Your Risk

If you or a family member has psoriasis, you've probably wondered: is this something I inherited? The short answer is yes - genetics play a major role. Twin studies estimate that 60% to 90% of psoriasis susceptibility is heritable, making it one of the most genetically influenced autoimmune conditions known to medicine (Lønnberg et al., 2013).

But inheriting psoriasis risk genes doesn't guarantee you'll develop the disease. About 125 million people worldwide - roughly 2% to 3% of the global population - live with psoriasis (World Psoriasis Day Consortium, 2024). Many carry risk variants and never develop a single plaque. Understanding the interplay between your DNA and environmental triggers is key to making sense of your personal risk.

How Heritable Is Psoriasis? What Twin Studies Tell Us

The strongest evidence for psoriasis genetics comes from twin studies. In the largest study to date, researchers examined over 33,000 Danish twins and found that identical (monozygotic) twins had a concordance rate of 33%, compared to 17% for fraternal (dizygotic) twins (Lønnberg et al., 2013). Genetic factors explained approximately 68% of the variation in psoriasis susceptibility.

Earlier studies reported even higher estimates. A meta-analysis of twin research found monozygotic concordance rates between 62% and 70%, with heritability estimates ranging from 60% to 90% (Liang et al., 2020). For context, that's comparable to the heritability of height - genetics clearly matter, but they don't tell the whole story.

The fact that identical twins don't always share psoriasis status (concordance is well below 100%) proves that environmental factors are essential triggers. Your genes load the gun; your environment pulls the trigger.

The Key Genes Behind Psoriasis

Genome-wide association studies (GWAS) have identified over 80 genetic loci linked to psoriasis susceptibility (Tsoi et al., 2012). Here are the most significant ones:

HLA-C*06:02 - The Strongest Risk Factor

The single most powerful genetic predictor of psoriasis is HLA-C*06:02 (formerly called HLA-Cw6), located within the PSORS1 locus on chromosome 6p21 (Nair et al., 2006). This region accounts for 35% to 50% of psoriasis heritability on its own (Genetic Epidemiology of Psoriasis, Dand et al., 2020).

HLA-C*06:02 is found in up to 85% of people with early-onset psoriasis (before age 40), compared to roughly 10% of the general population (Elder et al., 2010). Carriers of this allele typically experience:

• Earlier disease onset (teens to 30s rather than 50s+)
• More widespread plaque distribution
• Stronger response to certain biologic therapies
• Greater likelihood of guttate psoriasis after streptococcal infection

IL-23 Pathway Genes - IL23R, IL12B, and IL23A

A landmark GWAS published in Nature Genetics confirmed that three genes in the interleukin-23 (IL-23) signaling pathway - IL23R, IL12B, and IL23A - are strongly associated with psoriasis (Nair et al., 2009). The IL-23 pathway drives the activation of Th17 cells, which produce inflammatory molecules that accelerate skin cell turnover.

Individuals homozygous for predisposing variants at both IL12B and IL23R make up approximately 35% to 37% of psoriasis cases versus 24% to 27% of controls, with a combined odds ratio of 1.66 (Cargill et al., 2007). This discovery directly led to the development of IL-23-blocking biologics like guselkumab and risankizumab - a textbook example of genetics informing treatment.

Other Notable Genes

• TNFAIP3 and TNIP1 - regulate NF-κB inflammatory signaling (Nair et al., 2009)
• LCE3B/LCE3C - encode skin barrier proteins; deletions increase risk (de Cid et al., 2009)
• IL4/IL13 - involved in immune regulation and shared with atopic conditions
• DEFB4 - encodes beta-defensin, an antimicrobial peptide in skin

What If Your Parent Has Psoriasis? Understanding Family Risk

Family history is the most practical way to assess psoriasis risk before any genetic testing:

• One parent with psoriasis - approximately 15% chance the child develops it (Papaa, 2023)
• Both parents with psoriasis - risk jumps to roughly 75% (Papaa, 2023)
• One affected sibling - about 6% risk, compared to 2-3% in the general population (Dand et al., 2020)
• First-degree relative with psoriasis - 3-fold increased risk overall (Al-Mutairi et al., 2011)

These numbers reflect the polygenic nature of psoriasis - it's not a single-gene condition like cystic fibrosis. Dozens of common variants each contribute a small amount of risk, and their combined effect interacts with your environment.

Environmental Triggers: What Activates Psoriasis Genes

Having psoriasis risk genes is necessary but not sufficient. Research has identified several environmental factors that can trigger disease onset or flares in genetically susceptible individuals (Kamiya et al., 2019):

• Streptococcal throat infections - a classic trigger, especially for guttate psoriasis in HLA-C*06:02 carriers
• Psychological stress - activates the hypothalamic-pituitary-adrenal axis, promoting inflammation
• Smoking - associated with a dose-dependent increase in psoriasis risk and severity
• Obesity - adipose tissue produces pro-inflammatory cytokines that worsen psoriasis
• Certain medications - lithium, beta-blockers, and antimalarials can provoke flares
• Skin trauma - the Koebner phenomenon, where psoriasis develops at sites of injury
• Heavy alcohol use - linked to both higher incidence and poorer treatment response

Epigenetic mechanisms - changes in gene expression without altering the DNA sequence - may explain how these environmental factors "switch on" psoriasis genes. DNA methylation patterns differ significantly between psoriatic and healthy skin, suggesting that lifestyle choices can influence whether risk genes become active (Roberson & Bhatt, 2021).

What Can You Do With This Information?

1. Know Your Genetic Risk

If you have a family history of psoriasis, uploading your existing DNA data to a tool like GenomeInsight can help you check for key risk variants like HLA-C*06:02 and IL-23 pathway SNPs. Understanding your genetic profile empowers you to be proactive rather than reactive.

2. Manage Modifiable Triggers

You can't change your DNA, but you can influence the environmental side of the equation:

• Maintain a healthy weight - obesity both increases psoriasis risk and reduces treatment effectiveness
• Quit smoking - one of the strongest modifiable risk factors
• Manage stress through exercise, mindfulness, or therapy
• Limit alcohol consumption
• Treat streptococcal infections promptly

3. Discuss Pharmacogenomics With Your Doctor

The same genetic insights that explain psoriasis risk are transforming treatment. Biologic therapies targeting IL-23 (IL23R, IL12B) and TNF-α pathways were developed directly from GWAS findings. Your pharmacogenomic profile may also influence how you metabolize common psoriasis medications like methotrexate or cyclosporine.

4. Screen Family Members

If you have psoriasis, your children and siblings may benefit from awareness of their elevated risk. Early identification allows for trigger avoidance and faster diagnosis if symptoms appear.

Key Takeaways

• Psoriasis is highly heritable - genetics explain 60-90% of susceptibility based on twin studies
• HLA-C*06:02 is the single strongest genetic risk factor, present in up to 85% of early-onset cases
• Over 80 genetic loci contribute to psoriasis risk, with IL-23 pathway genes (IL23R, IL12B, IL23A) playing a central role
• Environmental triggers - stress, infections, smoking, obesity - activate psoriasis in genetically predisposed individuals
• Family risk is significant: 15% with one affected parent, 75% with two
• Your DNA data can reveal key risk variants - upload your raw data to explore your psoriasis genetics with GenomeInsight

Understanding your genetic risk for psoriasis isn't about predicting the future -- it's about gaining the knowledge to take control. Whether you're managing the condition or trying to prevent it, your DNA is a powerful starting point.

Ready to check your DNA? Upload your raw data for free and explore your psoriasis risk variants today.

Related Reading

• Is Rheumatoid Arthritis Genetic? -- another autoimmune condition with strong HLA gene associations and shared genetic pathways with psoriasis.
• Is Asthma Genetic? -- explore the genetics of another immune-mediated condition that often co-occurs with psoriasis.
• Polygenic Risk Scores Explained -- learn how researchers combine dozens of small-effect variants into a single score for complex conditions like psoriasis.

References

Al-Mutairi, N., & Al-Farag, S. (2011). Genetic background of psoriasis. Saudi Medical Journal, 32(3), 215–222.

Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., ... & Begovich, A. B. (2007). A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. American Journal of Human Genetics, 80(2), 273–290.

Dand, N., Mahil, S. K., Capon, F., Smith, C. H., Simpson, M. A., & Barker, J. N. (2020). Psoriasis and genetics. Acta Dermato-Venereologica, 100(3), adv00030.

de Cid, R., Riveira-Munoz, E., Zeeuwen, P. L., Robarge, J., Liao, W., Dannhauser, E. N., ... & Estivill, X. (2009). Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nature Genetics, 41(2), 211–215.

Elder, J. T., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Stuart, P. E., Tejasvi, T., ... & Nair, R. P. (2010). Molecular dissection of psoriasis: Integrating genetics and biology. Journal of Investigative Dermatology, 130(5), 1213–1226.

Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., & Ohtsuki, M. (2019). Risk factors for the development of psoriasis. International Journal of Molecular Sciences, 20(18), 4347.

Liang, Y., Sarkar, M. K., Tsoi, L. C., & Gudjonsson, J. E. (2020). Psoriasis: A mixed autoimmune and autoinflammatory disease. Current Opinion in Immunology, 49, 1–8.

Lønnberg, A. S., Skov, L., Skytthe, A., Kyvik, K. O., Pedersen, O. B., & Thomsen, S. F. (2013). Heritability of psoriasis in a large twin sample. British Journal of Dermatology, 169(2), 412–416.

Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D., ... & Elder, J. T. (2009). Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nature Genetics, 41(2), 199–204.

Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V., Jenisch, S., ... & Elder, J. T. (2006). Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. American Journal of Human Genetics, 78(5), 827–851.

Roberson, E. D., & Bhatt, D. (2021). Epigenetic mechanisms in psoriasis. Frontiers in Immunology, 12, 717386.

Tsoi, L. C., Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., ... & Elder, J. T. (2012). Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics, 44(12), 1341–1348.

World Psoriasis Day Consortium. (2024). Psoriasis statistics. National Psoriasis Foundation. https://www.psoriasis.org/psoriasis-statistics/

---

Related Reading

• lupus genetics